Title : Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy - Wattmo_2016_Alzheimers.Res.Ther_8_7 |
Author(s) : Wattmo C , Minthon L , Wallin AK |
Ref : Alzheimers Res Ther , 8 :7 , 2016 |
Abstract :
BACKGROUND: There is an increasing interest in cognitive and functional outcomes in the respective stages of Alzheimer's disease (AD) and in novel therapies particularly for the milder phases of AD. Our aim was to describe and compare various aspects of disease progression in patients with mild versus moderate AD in routine clinical practice of cholinesterase inhibitor (ChEI) therapy. |
PubMedSearch : Wattmo_2016_Alzheimers.Res.Ther_8_7 |
PubMedID: 26883213 |
Wattmo C, Minthon L, Wallin AK (2016)
Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy
Alzheimers Res Ther
8 :7
Wattmo C, Minthon L, Wallin AK (2016)
Alzheimers Res Ther
8 :7